New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A2622

Introduced
1/9/24  

Caption

"Prenatally and Postnatally Diagnosed Conditions Awareness Act in New Jersey."

Impact

This legislation is expected to amend New Jersey's health service operations by establishing a framework for granting, contracting, and cooperative agreements aimed at synthesizing and disseminating data related to prenatally and postnatally diagnosed conditions. Additionally, it allocates responsibilities to the Commissioner of Health and Senior Services to oversee the implementation of these programs, ensuring that healthcare providers prioritize partnerships with organizations advocating for those with disabilities. The goal is to foster an interconnected support system that can significantly benefit affected families.

Summary

Assembly Bill A2622, known as the 'Prenatally and Postnatally Diagnosed Conditions Awareness Act in New Jersey,' aims to improve the provision of supportive services for new or expecting parents receiving positive results from prenatal or postnatal testing for conditions like Down syndrome. The bill mandates that healthcare professionals provide comprehensive, evidence-based information about the implications of these diagnoses, including physical, developmental, educational, and psychosocial outcomes. It also requires referrals to supportive services and connects parents with peer support networks, creating a more informed and supportive environment for families facing these diagnoses.

Contention

One of the notable points of contention regarding A2622 involves concerns over resource allocation, particularly since the bill specifies no state funds shall be appropriated for its initiatives in the fiscal year following its enactment. This aspect raises questions about the sustainability of the programs it seeks to implement. Furthermore, discussions surrounding the bill indicate varying opinions on government involvement in public health education and whether existing healthcare frameworks can adequately handle the increased responsibilities without additional funding. The need for coordination with federal laws, such as the Prenatally and Postnatally Diagnosed Conditions Awareness Act, further underscores the complexities involved in enacting this legislation.

Companion Bills

NJ A1019

Carry Over "Prenatally and Postnatally Diagnosed Conditions Awareness Act in New Jersey."

Previously Filed As

NJ A3152

"Prenatally and Postnatally Diagnosed Conditions Awareness Act in New Jersey."

NJ AJR114

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ HB2307

Transferring the power to authorize and oversee certain activities regarding prenatal and postnatal diagnosed conditions awareness programs from the department of health and environment to the Kansas council on developmental disabilities.

NJ SJR88

Designates last day of February of each year as "Rare Disease Awareness Day" in New Jersey.

NJ SJR30

Designates October of each year as "Eczema Awareness Month" in New Jersey.

NJ A3150

"The New Jersey Healthcare Choice Act"; permits health insurers licensed in other states to provide coverage in New Jersey under certain circumstances.

NJ AJR43

Designates The Growing Stage Children's Theatre of New Jersey as New Jersey State children's theatre.

NJ AJR19

Designates May 7 of each year as "Cystinosis Awareness Day" in New Jersey.

NJ AJR14

Designates October 1 of each year as "New Jersey Diner Day".

NJ AJR30

Designates May of each year as "Skin Cancer Awareness Month" in New Jersey.

Similar Bills

No similar bills found.